We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOS icon
451
The Mosaic Company
MOS
$7.76B
$3.81M 0.04%
119,386
+86,724
+266% +$2.94M
AZN icon
452
AstraZeneca
AZN
$257B
$3.81M 0.04%
+31,796
New +$3.49M
EHC icon
453
Encompass Health
EHC
$11.9B
$3.81M 0.04%
+61,311
New +$4.09M
TFX icon
454
Teleflex
TFX
$5.88B
$3.8M 0.04%
+9,456
New +$3.87M
FYBR
455
DELISTED
Frontier Communications
FYBR
$3.8M 0.04%
+143,814
New +$3.62M
LUV icon
456
Southwest Airlines
LUV
$19.8B
$3.77M 0.04%
70,995
+14,243
+25% +$854K
OC icon
457
Owens Corning
OC
$11.7B
$3.77M 0.04%
+38,458
New +$3.84M
MKTX icon
458
MarketAxess Holdings
MKTX
$5.71B
$3.76M 0.04%
8,116
-1,679
-17% -$799K
WBD icon
459
Warner Bros
WBD
$71.6B
$3.76M 0.04%
122,460
-36,740
-23% -$1.27M
CWEN icon
460
Clearway Energy Class C
CWEN
$6.68B
$3.73M 0.04%
140,778
+15,545
+12% +$427K
VAC icon
461
Marriott Vacations Worldwide
VAC
$3.87B
$3.72M 0.04%
+23,357
New +$4M
BOX icon
462
Box
BOX
$4.56B
$3.69M 0.04%
144,218
+11,088
+8% +$258K
IAA
463
DELISTED
IAA, Inc. Common Stock
IAA
$3.68M 0.04%
67,548
+47,058
+230% +$2.7M
CLF icon
464
Cleveland-Cliffs
CLF
$6.43B
$3.68M 0.04%
170,653
+64,108
+60% +$1.26M
CHGG icon
465
Chegg
CHGG
$90.8M
$3.66M 0.04%
44,083
-13,757
-24% -$1.14M
ABBV icon
466
AbbVie
ABBV
$468B
$3.65M 0.04%
32,368
-62,225
-66% -$7.01M
AMTX icon
467
Aemetis
AMTX
$149M
$3.62M 0.04%
324,354
-121,098
-27% -$1.91M
TXT icon
468
Textron
TXT
$14.3B
$3.61M 0.04%
+52,531
New +$3.4M
CRI icon
469
Carter's
CRI
$1.31B
$3.55M 0.04%
+34,444
New +$3.51M
TXRH icon
470
Texas Roadhouse
TXRH
$13.4B
$3.55M 0.04%
36,891
+31,671
+607% +$3.12M
BALL icon
471
Ball Corp
BALL
$16.8B
$3.54M 0.04%
43,691
-48,607
-53% -$4.21M
GVA icon
472
Granite Construction
GVA
$5.5B
$3.53M 0.04%
+85,076
New +$3.38M
KMB icon
473
Kimberly-Clark
KMB
$36.4B
$3.52M 0.04%
26,307
+23,512
+841% +$3.14M
DDOG icon
474
Datadog
DDOG
$84.6B
$3.52M 0.04%
+33,799
New +$3.05M
PPL
475
PPL Corp
PPL
$25.9B
$3.52M 0.04%
125,675
-109,506
-47% -$3.16M

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.